Overview

Universal CAR-T Cell Therapy for MM

Status:
RECRUITING
Trial end date:
2028-04-18
Target enrollment:
Participant gender:
Summary
This trial aims to evaluate the safety and efficacy of BCMA-UCART in treating patients with r/r multiple myeloma.
Phase:
NA
Details
Lead Sponsor:
Bioray Laboratories
Collaborator:
Shanghai Tongji Hospital (Tongji Hospital of Tongji University)